- Home
- KPRX vs VS Comparison
KPRX vs VS Comparison
Compare KPRX & VS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- VS
- Stock Information
- Founded
- KPRX 1998
- VS 2013
- Country
- KPRX United States
- VS United States
- Employees
- KPRX N/A
- VS N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- VS EDP Services
- Sector
- KPRX Health Care
- VS Technology
- Exchange
- KPRX Nasdaq
- VS Nasdaq
- Market Cap
- KPRX 9.1M
- VS 10.1M
- IPO Year
- KPRX N/A
- VS N/A
- Fundamental
- Price
- KPRX $3.08
- VS $2.27
- Analyst Decision
- KPRX Strong Buy
- VS Hold
- Analyst Count
- KPRX 1
- VS 1
- Target Price
- KPRX $10.00
- VS $2.00
- AVG Volume (30 Days)
- KPRX 1.3M
- VS 22.8K
- Earning Date
- KPRX 05-09-2025
- VS 05-15-2025
- Dividend Yield
- KPRX N/A
- VS N/A
- EPS Growth
- KPRX N/A
- VS N/A
- EPS
- KPRX N/A
- VS N/A
- Revenue
- KPRX $20,000.00
- VS $230,132.00
- Revenue This Year
- KPRX N/A
- VS $3,459.21
- Revenue Next Year
- KPRX N/A
- VS N/A
- P/E Ratio
- KPRX N/A
- VS N/A
- Revenue Growth
- KPRX N/A
- VS 64.71
- 52 Week Low
- KPRX $2.51
- VS $1.00
- 52 Week High
- KPRX $5.55
- VS $9.59
- Technical
- Relative Strength Index (RSI)
- KPRX 48.79
- VS 64.03
- Support Level
- KPRX $2.90
- VS $2.01
- Resistance Level
- KPRX $4.18
- VS $2.10
- Average True Range (ATR)
- KPRX 0.26
- VS 0.10
- MACD
- KPRX 0.00
- VS 0.02
- Stochastic Oscillator
- KPRX 19.12
- VS 81.84
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About VS Versus Systems Inc.
Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.